Translate this page to:
Choose Language…
In JoVE (1)
Other Publications (1)
Articles by Janet L Anderl in JoVE
JoVE General
A Neuronal and Astrocyte Co-Culture Assay for High Content Analysis of Neurotoxicity
Bioscience Division, High Content Analysis Research and Development, Millipore Inc
This article describes a novel protocol and reagent set designed for sensitive measurement of neurotoxic effects of compounds and treatments on co-cultures of neurons and astrocytes using high content analysis. Results demonstrate that high content analysis represents an exciting novel technology for neurotoxicity assessment.
Other articles by Janet L Anderl on PubMed
Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adverse Events
Bortezomib (Velcade), a dipeptide boronate 20S proteasome inhibitor and an approved treatment option for multiple myeloma, is associated with a treatment-emergent, painful peripheral neuropathy (PN) in more than 30% of patients. Carfilzomib, a tetrapeptide epoxyketone proteasome inhibitor, currently in clinical investigation in myeloma, is associated with low rates of PN. We sought to determine whether PN represents a target-mediated adverse drug reaction (ADR).
